Literature DB >> 11582869

[Prevalence of HIV and HBs antigen in blood donors. Residual risk of contamination in blood recipients in East Kinshasa, Democratic Republic of the Congo].

C Mbendi Nlombi1, B Longo-Mbenza, S Mbendi Nsukini, J J Muyembe Tamfum, H Situakibanza Nanituma, D Vangu Ngoma.   

Abstract

Between January and August 1999, a total of 7277 blood donors at various health centers in Kinshasa, Democratic Republic of the Congo were screened for human immunodeficiency virus 1 (HIV1) and hepatitis B surface antigen (HbsAg) using the ELISA technique. Findings showed an incidence of 6.4% for HIV1 antibodies, 9.2% for HbsAg, and 1% for HIV1 and HbsAg. Young females (under 39 years of age) from lower socio-economic classes were the most likely to be infected by HIV1. The risk of HIV transmission by transfusion of contaminated blood was 3%, which is close to the incidence of HIV in the general population. The findings of this study document the need to speed up implementation of blood donor screening in the city of Kinshasa and the rest of the country.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11582869

Source DB:  PubMed          Journal:  Med Trop (Mars)        ISSN: 0025-682X


  10 in total

Review 1.  TB and HIV in the Central African region: current knowledge and knowledge gaps.

Authors:  S Janssen; M A M Huson; S Bélard; S Stolp; N Kapata; M Bates; M van Vugt; M P Grobusch
Journal:  Infection       Date:  2013-12-06       Impact factor: 3.553

2.  Use of seroconversion panels to estimate delay in detection of anti-human immunodeficiency virus antibodies by enzyme-linked immunosorbent assay of pooled compared to singleton serum samples.

Authors:  Lena Novack; Noya Galai; Arieh Yaari; Mordechai Orgel; Eilat Shinar; Batia Sarov
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

3.  Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment.

Authors:  Yan Liu; Felicia Wu
Journal:  Environ Health Perspect       Date:  2010-02-19       Impact factor: 9.031

4.  The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood.

Authors:  Erhabor Osaro; Adias Teddy Charles
Journal:  J Blood Med       Date:  2011-02-06

5.  Factors for viral infection in blood donors of South Kivu in the Democratic Republic of Congo.

Authors:  Jeff Maotela Kabinda; Dramaix-Wilmet Michèle; Philippe Donnen; Serge Ahuka Miyanga; Jef Van den Ende
Journal:  Pan Afr Med J       Date:  2014-12-17

6.  High Prevalence and Diversity of Hepatitis Viruses in Suspected Cases of Yellow Fever in the Democratic Republic of Congo.

Authors:  Sheila Makiala-Mandanda; Frédéric Le Gal; Nadine Ngwaka-Matsung; Steve Ahuka-Mundeke; Richard Onanga; Berthold Bivigou-Mboumba; Elisabeth Pukuta-Simbu; Athenaïs Gerber; Jessica L Abbate; Dieudonné Mwamba; Nicolas Berthet; Eric Maurice Leroy; Jean-Jacques Muyembe-Tamfum; Pierre Becquart
Journal:  J Clin Microbiol       Date:  2017-02-15       Impact factor: 5.948

7.  Prevalence of viral and non-viral hepatitis in Menoua Division, West Region, Cameroon: a retrospective hospital-based study.

Authors:  Mathias Kenfack Tsague; Agathe Lambou Fotio; Cyrille Lionel Kamga Bomgning; Georges Nguefack-Tsague; Francois Fopa; Télesphore Benoît Nguelefack
Journal:  Pan Afr Med J       Date:  2019-04-29

8.  [Prevalence of HBsAg and anti-HCV antibodies in homozygous sickle cell patients at Yaounde Central Hospital].

Authors:  Françoise Ngo Sack; Dominique Noah Noah; Haman Zouhaïratou; Dora Mbanya
Journal:  Pan Afr Med J       Date:  2013-01-28

9.  Seroprevalence of Human Immunodeficiency Virus, Hepatitis B Virus, Hepatitis C Virus, and Syphilis among Blood Donors at Jigjiga Blood Bank, Eastern Ethiopia.

Authors:  Melese Abate; Tesfaye Wolde
Journal:  Ethiop J Health Sci       Date:  2016-03

Review 10.  The HBsAg Prevalence Among Blood Donors From Eastern Mediterranean and Middle Eastern Countries: A Systematic Review and Meta-Analysis.

Authors:  Mehran Babanejad; Neda Izadi; Farid Najafi; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2016-03-26       Impact factor: 0.660

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.